Novozymes A/SBagsværd Denmark
Key Novozymes A/S Financials
| Company Type | Public -(OMX Copenhagen: NZYM B) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $1,729.9 |
| 2010 Employees | 5,432 |
Try a Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Limit your risk
Check your customers' credit with
D&B Credit Reports
Novozymes A/S Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1,729.9 | 1,627.1 | 1,542.9 |
| Cost of Goods Sold | 767.1 | 721.9 | 717.3 |
| Gross Profit | 962.8 | 905.2 | 825.6 |
| Gross Profit Margin | 55.7% | 55.6% | 53.5% |
| SG&A Expense | 356.5 | 360.0 | 342.1 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 376.6 | 325.1 | 284.9 |
| Operating Margin | 21.8% | 20% | 18.5% |
| Nonoperating Income | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | 1.1 | (12.9) | (16.1) |
| Income Before Taxes | 377.7 | 312.2 | 268.8 |
| Income Taxes | 90.6 | 82.2 | 67.6 |
| Net Income After Taxes | 287.1 | 230.0 | 201.1 |
| Continuing Operations | 287.1 | 230.0 | 201.1 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 287.1 | 230.0 | 201.1 |
| Total Net Income | 287.1 | 230.0 | 201.1 |
| Net Profit Margin | 16.6% | 14.1% | 13% |
| Diluted EPS from Total Net Income | 0.90 | 0.73 | 0.64 |
| Dividends per Share | 0.20 | 0.20 | -- |
All amounts in millions of US Dollars except per share amounts.
Novozymes A/S Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 260.6 | 247.3 | 188.8 |
| Net Receivables | -- | -- | -- |
| Inventories | 291.8 | 295.6 | 294.9 |
| Other Current Assets | 432.5 | 400.6 | 327.7 |
| Total Current Assets | 984.9 | 943.5 | 811.4 |
| Net Fixed Assets | 1,043.6 | 925.3 | 818.0 |
| Other Noncurrent Assets | 211.9 | 228.6 | 250.4 |
| Total Assets | 2,240.3 | 2,097.4 | 1,879.8 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 135.9 | 102.3 | 119.3 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 310.3 | 383.3 | 427.3 |
| Total Current Liabilities | 446.2 | 485.5 | 546.6 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 400.1 | 485.0 | 485.4 |
| Total Liabilities | 846.3 | 970.5 | 1,032.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 1,394.0 | 1,125.0 | 845.7 |
| Total Equity | 1,394.0 | 1,125.0 | 845.7 |
| Shares Outstanding (thou.) | 314,707.5 | 310,876.2 | 309,782.4 |
All amounts in millions of US Dollars except per share amounts.
Novozymes A/S Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 413 | 350 | 321 |
| Net Investing Cash Flow | (240.0) | (188.4) | (178.4) |
| Net Financing Cash Flow | (131.1) | (100.7) | 54.4 |
| Net Change in Cash | 46.6 | 61.4 | 201.1 |
| Depreciation & Amortization | |||
| Capital Expenditures | (236.4) | (196.5) | (181.6) |
| Cash Dividends Paid | (63.9) | (62.8) | (58.5) |
All amounts in millions of US Dollars except per share amounts.